failure following salvage therapy after prostatectomy is poorly understood. The objective of this study is to identify sites of cancer recurrence in patients who received hormonal therapy (HT), radiation therapy (RT) or combination of HT and RT following prostatectomy and subsequently developed PSA progression.
METHODS: Between January 2008 and June 2016, 2466 patients underwent imaging for PSA recurrence. From this cohort 216 received RT, HT or RT+HT postoperatively and underwent 11C-choline PET scan and mpMRI. Additionally, clinical factors (ie. PSA at imaging) associated with recurrence were also evaluated. Local recurrence was defined as positive imaging within prostate bed. Metastatic recurrence included recurrent disease of pelvic/distant nodes as well as osseous disease.
RESULTS: Among 216 patients with PSA progression, 26 (12.0%) patients exhibited local recurrence, 34 (15.8%) had local and distant metastatic disease, and 156 (72.2%) had metastatic disease. Table 1 describes patterns of recurrence. Mean PSA was 4.47, 6.87, and 10.63 in patients with local recurrence, local and metastatic recurrence, and metastatic recurrence, respectively (p¼0.21). When recurrence patterns were compared with postoperative treatment-naïve patients (Sobol et al JU 2016) , patients receiving postoperative therapy had higher rates of metastatic recurrence (72% vs. 44%) while treatment-naïve patients had higher rates of local recurrence (34% vs 12%; both p<0.0001).
CONCLUSIONS: Utilization of mpMRI and 11C-choline PET imaging in the evaluation of PSA progression after postoperative therapy reveals varied recurrence patterns, with the majority of patients having evidence of metastatic disease, when compared with a treatment-naïve cohort. Approximately 12% of patients who failed postoperative therapy after prostatectomy may be eligible for additional local therapy. Prudent utilization of advanced imaging techniques may optimize and guide therapeutic options among patients who develop PSA progression following postoperative therapy potentially avoiding unnecessary or ineffective treatments.
Source of Funding: None

MP77-05 SIMPLE PROSTATE BIOPSY PROTOCOL WITH AUGMENTED ANTIBIOTICS DECREASES COMPLICATIONS AND ADMISSIONS IN VETERANS
Kimberly A Maciolek*, Sara L Best, Wade A Bushman, David F Jarrard, Tracy M Downs, E Jason Abel, Kyle A Richards, Madison, WI INTRODUCTION AND OBJECTIVES: Complications following prostate biopsy are rare but can be devastating. The American Urologic Association (AUA) Quality Improvement Summit in 2014 recommended identifying high risk patients and considering augmented antibiotics. We prospectively implemented a biopsy protocol to identify high-risk patients for bleeding or infections and use augmented antibiotics with the objective of reducing complications.
METHODS: Overall, 637 consecutive patients from June 1, 2014 to August 30, 2016, who underwent prostate biopsy at our Veterans Affairs hospital were evaluated. The prostate biopsy protocol required the provider to document infectious risk factors including prior UTI, antibiotic exposure, and/or recent biopsy to alert the prescriber to substitute IM ceftriaxone for oral ciprofloxacin in high-risk patients. Patients were also monitored closer for bleeding after the biopsy, especially those driving 2 hours. We defined complications as any deviations from normal post-biopsy activities. Comparisons were made between pre/post protocol cohorts, and logistic regression was used to identify risk factors for admissions or complications.
RESULTS: The median age was 67 (IQR 64-69, p¼0.4) in both groups (pre n¼334, post n¼303). 45 patients were deemed high infectious risk with the following patient-reported events: 22 patients with antibiotics for recent UTI, 10 patients with history of complicated UTI/ prostatitis, 16 patients with prostate biopsies within 6 months and 3 patients with clean intermittent catheterization or indwelling catheter. Pre-protocol, 98.8% patients received ciprofloxacin empirically; postprotocol, 85.7% received ciprofloxacin and 14.3% received ceftriaxone (p<0.001). There were no deaths in either group. The 30-day complication rates pre-and post-protocol were 16.2% and 8.5% (p¼0.001) with infectious complication rates of 1.2% and 1.7% (p¼0.74). There was a decrease in 30-day hospitalization rate in the post-protocol group vs. the pre-protocol group (1% vs. 3.6%, p¼0.04). On logistic regression, there were reduced odds of 30-day complications (OR 0.48, p¼0.004) and 30-day hospitalization (OR 0.27, p¼0.04) in the postprotocol group.
CONCLUSIONS: A screening protocol for bleeding and infectious risks prior to prostate biopsy provides a more targeted approach for selecting prophylactic antibiotics and closer monitoring post-biopsy for bleeding. Rates of infection overall were quite low. Our results suggest that the protocol has a favorable impact on complication and hospitalization rates.
Source of Funding: None
MP77-06
ANTIMICROBIAL LUBRICANT REDUCES RECTAL BACTERIA AT TRANSRECTAL PROSTATE BIOPSY.
RESULTS FROM A LARGE PROSPECTIVE RANDOMIZED TRIAL
Katharina Boehm*, Mainz, Germany; Sandra Prues, Judith Saul, Lars Bud€ aus, Derya Tilki, Hamburg, Germany; Axel Haferkamp, Mainz, Germany; Markus Graefen, Georg Salomon, Hamburg, Germany INTRODUCTION AND OBJECTIVES: Antibiotic resistancy may lead to increasing infection rates at transrectal prostate biopsy (PBx). Previous studies showed promising results by using targeted antibiotic therapy by rectal swab culture. Nonetheless, performing rectal swabs may be time-and cost ineffective. In consequence, there is a strong need for agents that can achieve a reduction of bacteria. Aim of our study was to test, if an antimicrobial lubricant can reduce bacteria.
METHODS: Study population consisted of 384 pbx patients who received a rectal swab before and after biopsy in an European single center between March 2013 and June 2015. Patients were randomized for biopsy with pre-interventional instillation of an antimicrobial lubricant (intervention group) or with standard lubricant (control group). Bacteria were semi-quantitatively recorded ( 20 colonies: [+]; > 20 colonies, growth only within first streak: +; growth in second streak: ++; growth in third streak: +++). Colonies growing within the ciprofloxacin inhibition zone were identified. RESULTS: Overall, 384 patients were included in the study. Out of them, 256 (66.7%) were in the intervention group and received antimicrobial lubricant, 128 (33.3%) were in the control group. Median age at biopsy was 65 years and mean PSA-levels was 7.5 ng/ml. In patients of the intervention group, semi-quantitative bacterial count was statistically significantly lower after instillation of antimicrobial lubricant(p<0.001). In the control group, no statistically significant difference was recorded at the bacteria count of the second rectal swab vs. bacteria count of the first rectal swab(p¼0.4). Ciprofloxacin-resistance was shown in overall 30 (7.8%) patients. Instillation of antimicrobial lubricant reduced ciprofloxacin-resistant bacteria from 24 (9.4%) to 15 (5.9%), but reduction did not achieve statistical significance Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e1023
